Literature DB >> 23336086

Immune Evasion by B-cell Lymphoma.

Jason M God1, Azizul Haque.   

Abstract

Entities:  

Year:  2011        PMID: 23336086      PMCID: PMC3547597          DOI: 10.4172/2155-9899.1000e103

Source DB:  PubMed          Journal:  J Clin Cell Immunol


× No keyword cloud information.
  18 in total

1.  Burkitt lymphoma.

Authors:  Eva Klein; George Klein
Journal:  Semin Cancer Biol       Date:  2009-12       Impact factor: 15.707

Review 2.  Controversies in the treatment of Burkitt lymphoma in AIDS.

Authors:  Ariela Noy
Journal:  Curr Opin Oncol       Date:  2010-09       Impact factor: 3.645

3.  Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol.

Authors:  M Diviné; P Casassus; S Koscielny; J Bosq; C Sebban; C Le Maignan; A Stamattoulas; B Dupriez; M Raphaël; J-L Pico; V Ribrag
Journal:  Ann Oncol       Date:  2005-11-10       Impact factor: 32.976

4.  CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.

Authors:  M Matloubian; R J Concepcion; R Ahmed
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

5.  High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: comparison of results in human immunodeficiency virus-infected and noninfected patients.

Authors:  Albert Oriol; Josep-Maria Ribera; Juan Bergua; Eduardo Giménez Mesa; Carlos Grande; Jordi Esteve; Salut Brunet; Maria-Jose Moreno; Lourdes Escoda; Jesus-Maria Hernandez-Rivas; Dieter Hoelzer
Journal:  Cancer       Date:  2008-07-01       Impact factor: 6.860

Review 6.  Improving outcomes for patients with Burkitt lymphoma and HIV.

Authors:  Victoria S Blinder; Amy Chadburn; Richard R Furman; Susan Mathew; John P Leonard
Journal:  AIDS Patient Care STDS       Date:  2008-03       Impact factor: 5.078

Review 7.  Epstein-Barr virus and its role in the pathogenesis of Burkitt's lymphoma: an unresolved issue.

Authors:  Georg W Bornkamm
Journal:  Semin Cancer Biol       Date:  2009-07-18       Impact factor: 15.707

Review 8.  Adult Burkitt lymphoma: advances in diagnosis and treatment.

Authors:  Ibrahim T Aldoss; Dennis D Weisenburger; Kai Fu; Wing C Chan; Julie M Vose; Philip J Bierman; R Gregory Bociek; James O Armitage
Journal:  Oncology (Williston Park)       Date:  2008-11-30       Impact factor: 2.990

9.  Burkitt lymphoma: pathogenesis and immune evasion.

Authors:  Jason M God; Azizul Haque
Journal:  J Oncol       Date:  2010-10-05       Impact factor: 4.375

Review 10.  Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.

Authors:  Martin Rowe; Gemma L Kelly; Andrew I Bell; Alan B Rickinson
Journal:  Semin Cancer Biol       Date:  2009-07-18       Impact factor: 15.707

View more
  4 in total

1.  A Missing Link between Neuron Specific Enolase Release and Poor Prognosis in Aging Patients with B-cell Lymphoma.

Authors:  Rachel Polcyn; Jason God; Mollie Capone; Denise Matzelle; Naren L Banik; Azizul Haque
Journal:  J Clin Cell Immunol       Date:  2018-05-15

2.  Non-invasive bioluminescence imaging to monitor the immunological control of a plasmablastic lymphoma-like B cell neoplasia after hematopoietic cell transplantation.

Authors:  Martin Chopra; Sabrina Kraus; Stefanie Schwinn; Miriam Ritz; Katharina Mattenheimer; Anja Mottok; Andreas Rosenwald; Hermann Einsele; Andreas Beilhack
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240

Review 3.  Burkitt's lymphoma masquerading as appendicitis--two case reports and review of the literature.

Authors:  Elroy P Weledji; Marcelin N Ngowe; John S Abba
Journal:  World J Surg Oncol       Date:  2014-06-18       Impact factor: 2.754

4.  Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program.

Authors:  Massimo Granai; Lucia Mundo; Ayse U Akarca; Maria Chiara Siciliano; Hasan Rizvi; Virginia Mancini; Noel Onyango; Joshua Nyagol; Nicholas Othieno Abinya; Ibrahim Maha; Sandra Margielewska; Wenbin Wi; Michele Bibas; Pier Paolo Piccaluga; Leticia Quintanilla-Martinez; Falko Fend; Stefano Lazzi; Lorenzo Leoncini; Teresa Marafioti
Journal:  Infect Agent Cancer       Date:  2020-05-06       Impact factor: 2.965

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.